Literature DB >> 11703335

Endothelial dysfunction in patients with polycythaemia vera.

T Neunteufl1, S Heher, T Stefenelli, I Pabinger, H Gisslinger.   

Abstract

Patients with polycythaemia vera (PV) are at increased risk of developing arterial and venous thromboembolic complications. We investigated whether endothelium-dependent, flow-mediated vasodilatation (FMD) is impaired in PV patients without clinical evidence of artery disease as observed in patients with conventional cardiovascular risk factors. FMD and endothelium-independent, nitroglycerine-induced vasodilatation (NMD) were assessed using high-resolution ultrasound in the brachial artery of 20 patients with PV and 20 sex- and age-matched control subjects (CTL). FMD was markedly impaired in PV patients compared with CTL (7.6 +/- 2.9% versus 11.6 +/- 5.7%, P = 0.009) whereas NMD was similar in both study groups. The impairment of FMD was independently related to the presence of PV (r = -0.434, P = 0.009) and vessel size (r = -0.107, P = 0.038) but was not related to haematocrit values and platelet counts. The results demonstrate that PV is associated with endothelial dysfunction in the pre-clinical phase of arterial disease. However, the precise mechanisms by which PV leads to this altered vascular reactivity remain unclear.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703335     DOI: 10.1046/j.1365-2141.2001.03092.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients.

Authors:  Raffaele Maio; Angela Sciacqua; Rosamaria Bruni; Alessandra Pascale; Giuseppe Carullo; Paola E Scarpino; Desirée Addesi; Ines Spinelli; Giulia Galiano Leone; Francesco Perticone
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

2.  Preserved flow-mediated dilation in adults with cyanotic congenital heart disease.

Authors:  Christian M Pedersen; Michael R Schmidt; Bente Mortensen; Hussain Contractor; Hans Erik Bøtker; Rajesh K Kharbanda; Keld E Sørensen
Journal:  Pediatr Cardiol       Date:  2009-07-30       Impact factor: 1.655

3.  Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.

Authors:  Lamia Lamrani; Catherine Lacout; Véronique Ollivier; Cécile V Denis; Elizabeth Gardiner; Benoit Ho Tin Noe; William Vainchenker; Jean-Luc Villeval; Martine Jandrot-Perrus
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

4.  An Evaluation of the Impact of Therapeutic Phlebotomy on Systemic Endothelial Functions in Polycythemic Patients with the Flow-Mediated Vasodilatation Method.

Authors:  Muzaffer Keklik; Ugur Kalan; Eyup Ozkan; Serdal Korkmaz; Bahadir Sarli
Journal:  Indian J Hematol Blood Transfus       Date:  2016-12-07       Impact factor: 0.900

Review 5.  Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disorders.

Authors:  Ruben A Mesa
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Excessive erythrocytosis compromises the blood-endothelium interface in erythropoietin-overexpressing mice.

Authors:  Vincent Richter; Michele D Savery; Max Gassmann; Oliver Baum; Edward R Damiano; Axel R Pries
Journal:  J Physiol       Date:  2011-08-22       Impact factor: 5.182

Review 7.  Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.

Authors:  Alexandre Guy; Johanne Poisson; Chloe James
Journal:  Leukemia       Date:  2021-03-03       Impact factor: 11.528

8.  Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients.

Authors:  Zanzhe Yu; Boon Kay Tan; Stephen Dainty; Derek L Mattey; Simon J Davies
Journal:  Nephrol Dial Transplant       Date:  2012-04-19       Impact factor: 5.992

9.  Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders.

Authors:  Polina I Kuznetsova; Anton A Raskurazhev; Rodion N Konovalov; Marina V Krotenkova; Andrey O Chechetkin; Olga V Lagoda; Anait L Melikhyan; Marine M Tanashyan
Journal:  J Clin Med       Date:  2021-12-21       Impact factor: 4.241

10.  Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm.

Authors:  Johanne Poisson; Marion Tanguy; Hortense Davy; Fatoumata Camara; Marie-Belle El Mdawar; Marouane Kheloufi; Tracy Dagher; Cécile Devue; Juliette Lasselin; Aurélie Plessier; Salma Merchant; Olivier Blanc-Brude; Michèle Souyri; Nathalie Mougenot; Florent Dingli; Damarys Loew; Stephane N Hatem; Chloé James; Jean-Luc Villeval; Chantal M Boulanger; Pierre-Emmanuel Rautou
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.